1.Pectorobrachioepicondylaris musculoaponeurotic band: case description with evidence of median nerve compression
Ana CARRERA ; Arada CHAIYAMOON ; Francisco REINA ; Joe IWANAGA ; Aida CATEURA ; Miguel Angel REINA ; José Ramón SAÑUDO ; R. Shane TUBBS
Anatomy & Cell Biology 2023;56(2):280-284
Upper limb muscle variations can be encountered on imaging or at surgery. We report an unusual muscle and band found during routine dissection of the arm in a cadaver. This case is described and salient literature reviewed. A band was found that traveled from the insertion of the pectoralis major tendon distally and obliquely toward the medial intermuscular septum and medical epicondyle. Fibers of the brachialis were found to interdigitate into the band. A tunnel was formed that carried the median nerve and brachial vessels. Evidence of median nerve compression was observed. We considered this an example of a pectorobrachioepicondylaris muscle. However, some can lead to clinical presentations. Although the significance of the case reported herein is not certain, signs of median nerve compression were identified. We believe that the term pectorobrachioepicondylaris bests describes the muscle reported herein and that our case represents a previously unreported variant of this muscle.
2.Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study.
Elena Maria YUBERO-SERRANO ; Javier DELGADO-LISTA ; Patricia PENA-ORIHUELA ; Pablo PEREZ-MARTINEZ ; Francisco FUENTES ; Carmen MARIN ; Isaac TUNEZ ; Francisco JOSE TINAHONES ; Francisco PEREZ-JIMENEZ ; Helen M ROCHE ; Jose LOPEZ-MIRANDA
Experimental & Molecular Medicine 2013;45(6):e28-
Previous evidence supports the important role that oxidative stress (OxS) plays in metabolic syndrome (MetS)-related manifestations. We determined the relationship between the number of MetS components and the degree of OxS in MetS patients. In this comparative cross-sectional study from the LIPGENE cohort, a total of 91 MetS patients (43 men and 48 women; aged between 45 and 68 years) were divided into four groups based on the number of MetS components: subjects with 2, 3, 4 and 5 MetS components (n=20, 31, 28 and 12, respectively). We measured ischemic reactive hyperemia (IRH), plasma levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), total nitrite, lipid peroxidation products (LPO), hydrogen peroxide (H2O2), superoxide dismutase (SOD) and glutathione peroxidase (GPx) plasma activities. sVCAM-1, H2O2 and LPO levels were lower in subjects with 2 or 3 MetS components than subjects with 4 or 5 MetS components. IRH and total nitrite levels were higher in subjects with 2 or 3 MetS components than subjects with 4 or 5 MetS components. SOD and GPx activities were lower in subjects with 2 MetS components than subjects with 4 or 5 MetS components. Waist circumference, weight, age, homeostatic model assessment-beta, triglycerides (TGs), high-density lipoprotein and sVCAM-1 levels were significantly correlated with SOD activity. MetS subjects with more MetS components may have a higher OxS level. Furthermore, association between SOD activity and MetS components may indicate that this variable could be the most relevant OxS biomarker in patients suffering from MetS and could be used as a predictive tool to determine the degree of the underlying OxS in MetS.
Aged
;
Anthropometry
;
Antioxidants/metabolism
;
Biological Markers/metabolism
;
Blood Pressure
;
Endothelium, Vascular/pathology/physiopathology
;
Female
;
Glutathione Peroxidase/blood
;
Humans
;
Hydrogen Peroxide/metabolism
;
Hyperemia/blood/physiopathology
;
Male
;
Metabolic Syndrome X/blood/enzymology/*pathology/physiopathology
;
Middle Aged
;
Nitrites/blood
;
*Oxidative Stress
;
Regression Analysis
;
Superoxide Dismutase/blood
;
Vascular Cell Adhesion Molecule-1/metabolism
3.An unusual arrangement between the highest denticulate ligament and posterior inferior cerebellar artery
Aditi PATEL ; Johnathan BAUDOIN ; Arada CHAIYAMOON ; Juan J. CARDONA ; Ana CARRERA ; Francisco REINA ; Joe IWANAGA ; Aaron S. DUMONT ; R. Shane TUBBS
Anatomy & Cell Biology 2023;56(3):394-397
The posterior inferior cerebellar artery (PICA) is often involved in pathologies of the posterior cranial fossa. Therefore, a good understanding of the vessel’s normal and variant courses is important to the neurosurgeon or neurointerventionalist. During the routine microdissection of the craniocervical junction, an unusual arrangement between the highest denticulate ligament and PICA was observed. On the right side, the PICA was given rise to by the V4 segment of the vertebral artery 9 mm after the artery entered the dura mater of the posterior cranial fossa. The artery made an acute turn around the lateral edge of the highest denticulate ligament to then recur 180 degrees and travel medially toward the brainstem. Invasive procedures that target the PICA should be aware of the variant as described herein.
4.The laryngopharyngeal nerve: a comprehensive review
Stephen SHAPIRO ; Andrew L. PARKER ; Juan J. CARDONA ; Arada CHAIYAMOON ; Francisco REINA ; Ana CARRERA ; Joe IWANAGA ; Aaron S. DUMONT ; R. Shane TUBBS
Anatomy & Cell Biology 2023;56(3):299-303
The laryngopharyngeal nerve has received much less attention that the other contributions to the pharyngeal plexus i.e., glossopharyngeal and vagus nerves. Often, in descriptions and depictions, the nerve is simply labeled as the sympathetic contribution to the pharyngeal plexus. As there is such scant information available regarding this nerve, the present review was performed. Very little is found in the extant medical literature regarding the laryngopharyngeal nerve. However, based on available data, the nerve is a consistent contributory to the pharyngeal plexus and serves other adjacent areas e.g., carotid body. Therefore, a better understanding of this structure’s anatomy is important for those who operate in this area. Further studies are necessary to better elucidate the true function of the laryngopharyngeal nerve.
5.Mechanics Predicts Effective Critical-Size Bone Regeneration Using 3D-Printed Bioceramic Scaffolds
Pablo BLÁZQUEZ-CARMONA ; Juan MORA-MACIÁS ; Francisco J. MARTI´NEZ-VÁZQUEZ ; Juan MORGAZ ; Jaime DOMI´NGUEZ ; Esther REINA-ROMO
Tissue Engineering and Regenerative Medicine 2023;20(6):893-904
BACKGROUND:
3D-printed bioceramic scaffolds have gained popularity due to their controlled microarchitecture and their proven biocompatibility. However, their high brittleness makes their surgical implementation complex for weightbearing bone treatments. Thus, they would require difficult-to-instrument rigid internal fixations that limit a rigorous evaluation of the regeneration progress through the analysis of mechanic-structural parameters.
METHODS:
We investigated the compatibility of flexible fixations with fragile ceramic implants, and if mechanical monitoring techniques are applicable to bone tissue engineering applications. Tissue engineering experiments were performed on 8 ovine metatarsi. A 15 mm bone segment was directly replaced with a hydroxyapatite scaffold and stabilized by an instrumented Ilizarov-type external fixator. Several in vivo monitoring techniques were employed to assess the mechanical and structural progress of the tissue.
RESULTS:
The applied surgical protocol succeeded in combining external fixators and subject-specific bioceramic scaffolds without causing fatal fractures of the implant due to stress concentrator. The bearing capacity of the treated limb was initially altered, quantifying a 28–56% reduction of the ground reaction force, which gradually normalized during the consolidation phase. A faster recovery was reported in the bearing capacity, stiffening and bone mineral density of the callus. It acquired a predominant mechanical role over the fixator in the distribution of internal forces after one postsurgical month.
CONCLUSION
The bioceramic scaffold significantly accelerated in vivo the bone formation compared to other traditional alternatives in the literature (e.g., distraction osteogenesis). In addition, the implemented assessment techniques allowed an accurate quantitative evaluation of the bone regeneration through mechanical and imaging parameters.
6.Characteristics and in-hospital mortality of elderly patients with heart failure in Spanish hospitals.
Alberto ESTEBAN-FERNÁNDEZ ; Manuel ANGUITA-SÁNCHEZ ; Juan Luis BONILLA-PALOMAS ; María ANGUITA-GÁMEZ ; María GARCÍA ; José Luis BERNAL ; Náyade Del PRADO ; Cristina FERNÁNDEZ-PÉREZ ; Julián PÉREZ-VILLACASTIN ; Juan José GÓMEZ-DOBLAS ; Francisco Javier ELOLA
Journal of Geriatric Cardiology 2023;20(4):247-255
BACKGROUND:
The prevalence of heart failure (HF) increases with age, and it is one of the leading causes of hospitalization and death in older patients. However, there are little data on in-hospital mortality in patients with HF ≥ 75 years in Spain.
METHODS:
A retrospective analysis of the Spanish Minimum Basic Data Set was performed, including all HF episodes discharged from public hospitals in Spain between 2016 and 2019. Coding was performed using the International Classification of Diseases, 10th Revision. Patients ≥ 75 years with HF as the principal diagnosis were selected. We calculated: (1) the crude in-hospital mortality rate and its distribution according to age and sex; (2) the risk-standardized in-hospital mortality ratio; and (3) the association between in-hospital mortality and the availability of an intensive cardiac care unit (ICCU) in the hospital.
RESULTS:
We included 354,792 HF episodes of patients over 75 years. The mean age was 85.2 ± 5.5 years, and 59.2% of patients were women. The most frequent comorbidities were renal failure (46.1%), diabetes mellitus (35.5%), valvular disease (33.9%), cardiorespiratory failure (29.8%), and hypertension (26.9%). In-hospital mortality was 12.7%, and increased with age [odds ratio (OR) = 1.07, 95% CI: 1.07-1.07, P < 0.001] and was lower in women (OR = 0.96, 95% CI: 0.92-0.97, P < 0.001). The main predictors of mortality were the presence of cardiogenic shock (OR = 19.5, 95% CI: 16.8-22.7, P < 0.001), stroke (OR = 3.5, 95% CI: 3.0-4.0, P < 0.001) and advanced cancer (OR = 2.6, 95% CI: 2.5-2.8, P < 0.001). In hospitals with ICCU, the in-hospital risk-adjusted mortality tended to be lower (OR = 0.85, 95% CI: 0.72-1.00, P = 0.053).
CONCLUSIONS
In-hospital mortality in patients with HF ≥ 75 years between 2016 and 2019 was 12.7%, higher in males and elderly patients. The main predictors of mortality were cardiogenic shock, stroke, and advanced cancer. There was a trend toward lower mortality in centers with an ICCU.